The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cpda-1
Anticoagulant Citrate Phosphate Dextrose Adenine · DEXTROSE MONOHYDRATE 2 g/63mL; TRISODIUM CITRATE DIHYDRATE 1.66 g/63mL; ANHYDROUS CITRIC ACID 188 mg/63mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 140 mg/63mL; ADENINE 17.3 mg/63mL · Solution · Intravenous · Fenwal, Inc.
NDC 00942-9398-02 · 63 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Fenwal International, Inc.United Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BN770420
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Anticoagulant Citrate Phosphate Dextrose Adenine (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 2 g/63mL; TRISODIUM CITRATE DIHYDRATE 1.66 g/63mL; ANHYDROUS CITRIC ACID 188 mg/63mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 140 mg/63mL; ADENINE 17.3 mg/63mL | Aug 26, 2026 | Sep 3, 2026 |
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 2.23 g/70mL; TRISODIUM CITRATE DIHYDRATE 1.84 g/70mL; ANHYDROUS CITRIC ACID 209 mg/70mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 155 mg/70mL; ADENINE 19.3 mg/70mL | Aug 26, 2026 | Sep 3, 2026 |
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 17.3 mg/63mL; TRISODIUM CITRATE DIHYDRATE 188 mg/63mL; ANHYDROUS CITRIC ACID 2 g/63mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 140 mg/63mL; ADENINE 1.66 g/63mL | Jul 22, 2026 | Aug 22, 2026 |
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 19.3 mg/70mL; TRISODIUM CITRATE DIHYDRATE 209 mg/70mL; ANHYDROUS CITRIC ACID 2.23 g/70mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 155 mg/70mL; ADENINE 1.84 g/70mL | Jul 22, 2026 | Aug 22, 2026 |
| Fenwal, Inc. | ADENINE 17.3 mg/63mL; ANHYDROUS CITRIC ACID 188 mg/63mL; DEXTROSE MONOHYDRATE 2 g/63mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 140 mg/63mL; TRISODIUM CITRATE DIHYDRATE 1.66 g/63mL | Jul 15, 2026 | Jul 19, 2026 |
| Fenwal, Inc. | ADENINE 19.3 mg/70mL; ANHYDROUS CITRIC ACID 209 mg/70mL; DEXTROSE MONOHYDRATE 2.23 g/70mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 155 mg/70mL; TRISODIUM CITRATE DIHYDRATE 1.84 g/70mL | Jul 15, 2026 | Jul 19, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Cpda-1 — NDC 00942-9398-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00942939802.
Free to cite with attribution — see how the data is put together.